Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma

Item Type:Article
Title:A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma
Creators Name:Morris, J.C. and Ramsey, W.J. and Wildner, O. and Muslow, H.A. and Aguilar-Cordova, E. and Blaese, R.M.
Source:Human Gene Therapy
ISSN:1043-0342
Publisher:Mary Ann Liebert (U.S.A.)
Volume:11
Page Range:487-503
Date:10 February 2000
Official Publication:https://doi.org/10.1089/10430340050015950
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library